I agree that this site is using cookies. You can find further informations here.
X
McCullough, Kristen
143  results:
Search for persons X
?
1

The impact of cytotoxic therapy on the risk of progression ..:

Li, Marissa ; Baranwal, Anmol ; Gurney, Mark...
Blood Advances.  8 (2024)  12 - p. 3130-3139 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Cardiac events in newly diagnosed acute myeloid leukaemia d..:

Johnson, Isla M. ; Karrar, Omer ; Rana, Masooma...
British Journal of Haematology.  204 (2024)  4 - p. 1232-1237 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Cladribine plus cytarabine plus venetoclax in acute myeloid..:

Steinauer, Nickolas ; McCullough, Kristen ; Al-Kali, Aref...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

Pilot Prospective Study of Reduced Intensity Conditioning A..:

Mangaonkar, Abhishek ; Langer, Kimberly J. ; Lasho, Terra...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S292 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Clinical and molecular spectrum and prognostic outcomes of ..:

Pritzl, Stephanie L. ; Gurney, Mark ; Badar, Talha...
Leukemia Research.  125 (2023)  - p. 107007 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Molecular predictors of response and survival following IDH..:

Gangat, Naseema ; McCullough, Kristen ; Abdelmagid, Maymona...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
7

Spectrum of renal pathological findings in patients with ch..:

Gipe, Nate ; Leung, Nelson ; Lasho, Terra...
American Journal of Hematology.  98 (2023)  6 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
8

Venetoclax and hypomethylating agent combination therapy in..:

Gangat, Naseema ; Karrar, Omer ; Iftikhar, Moazah...
American Journal of Hematology.  99 (2023)  2 - p. 193-202 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Venetoclax duration (14 vs. 21 vs. 28 days) in combination ..:

Karrar, Omer ; Abdelmagid, Maymona ; Rana, Masooma...
American Journal of Hematology.  99 (2023)  2 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
10

Mast cell cytomorphology and treatment outcome in mast cell..:

Tefferi, Ayalew ; Pardanani, Animesh ; Al‐Kali, Aref...
American Journal of Hematology.  99 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
11

Outcome of patients with acute myeloid leukemia following f..:

Gangat, Naseema ; Ilyas, Rimal ; Johnson, Isla M...
Haematologica.  108 (2023)  11 - p. 3170-3174 , 2023
Link: https://doi.org/10.3324/..
 
?
12

Abnormal karyotype is an independent predictor of inferior ..:

Abdallah, Mostafa ; McCullough, Kristen ; Ilyas, Rimal...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferati..:

Ilyas, Rimal ; McCullough, Kristen ; Badar, Talha...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
14

IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferat..:

Gangat, Naseema ; Ajufo, Helen ; Abdelmagid, Maymona...
British Journal of Haematology.  203 (2023)  3 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
15

Real‐world experience with venetoclax and hypomethylating a..:

Gangat, Naseema ; McCullough, Kristen ; Johnson, Isla...
American Journal of Hematology.  97 (2022)  6 - p. , 2022
Link: https://doi.org/10.1002/..
 
1-15